Raschwitz Laura S, El-Battrawy Ibrahim, Schlentrich Kim, Besler Johanna, Veith Michael, Roterberg Gretje, Liebe Volker, Schimpf Rainer, Lang Siegfried, Wolpert Christian, Zhou Xiaobo, Akin Ibrahim, Borggrefe Martin
First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany.
DZHK (German Centre for Cardiovascular Research) Partner Site Heidelberg/Mannheim, Mannheim, Germany.
Front Genet. 2020 Jan 17;10:1312. doi: 10.3389/fgene.2019.01312. eCollection 2019.
Short QT syndrome (SQTS) is a rare syndrome and affects different types of genes. However, data on differences of clinical profile and outcome of different SQTS types are sparse.
We conducted a pooled analysis of 110 SQTS patients. Patients have been diagnosed between 2000 and 2017 at our institution (n = 12) and revealed using a literature review (n = 98). 29 studies were identified by analysing systematic data bases (PubMed, Web of Science, Cochrane Libary, Cinahl).
67 patients with genotype positive SQTS origin and 43 patients with genotype negative origin were found. A significant difference is documented between the sex with a higher predominance of male in genotype negative SQTS patients and predominance of females in genotype positive SQTS patients (male 52% versus 84%, female 45% versus 14%; p = 0.0016). No relevant difference of their median age (genotype positive 27 ± 19 versus genotype negative 29 ± 15; p = 0.48) was found. Asymptomatic patients and patients reporting symptoms such as syncope, sudden cardiac death, atrial flutter and ventricular fibrillation documented in both groups were similar except atrial fibrillation (genotype positive 19% versus genotype negative 0%; p = 0.0055). The QTc interval was not significantly different in both groups (genotype positive 315 ± 32 versus genotype negative 320 ± 19; p = 0.30). The treatments (medical treatment and ICD implantation) in both groups were comparable. Electrophysiology studies were not significantly higher documented in patients with genotype positive and negative origin (24% versus 9%; p = 0.075). Events at follow up such as VT, VF, and SCD were not higher presented in patients with genotype positive (13% versus 9%) (p = 0.25). 54% of genotype positive SQTS patients showed SQTS 1 followed by STQS 2 (21%) and SQTS 3 (10%).
The long-term risk of a malignant arrhythmic event is not higher in patients with genotype positive. However, patients with genotype positive present themselves more often with AF with a female predominance. Also, other events at follow up such as syncope, atrial flutter and palpitation were not significantly higher (9% versus 0%; p = 0.079).
短QT综合征(SQTS)是一种罕见综合征,影响不同类型的基因。然而,关于不同类型SQTS临床特征和预后差异的数据较为稀少。
我们对110例SQTS患者进行了汇总分析。2000年至2017年期间在我们机构确诊的患者有12例(n = 12),其余通过文献回顾确定(n = 98)。通过分析系统数据库(PubMed、科学网、Cochrane图书馆、护理学与健康领域数据库)确定了29项研究。
发现67例基因型阳性起源的SQTS患者和43例基因型阴性起源的患者。记录到基因型阴性的SQTS患者中男性占比更高,而基因型阳性的SQTS患者中女性占比更高,二者存在显著差异(男性分别为52%和84%,女性分别为45%和14%;p = 0.0016)。未发现两组患者的中位年龄有显著差异(基因型阳性为27±19岁,基因型阴性为29±15岁;p = 0.48)。两组中无症状患者以及报告有晕厥、心源性猝死、心房扑动和室性颤动等症状的患者相似,但心房颤动除外(基因型阳性为19%,基因型阴性为0%;p = 0.0055)。两组的QTc间期无显著差异(基因型阳性为315±32,基因型阴性为320±19;p = 0.30)。两组的治疗(药物治疗和植入式心律转复除颤器)具有可比性。基因型阳性和阴性起源的患者中进行电生理检查的比例差异无统计学意义(24%对9%;p = 0.075)。随访期间发生室性心动过速(VT)、室性颤动(VF)和心源性猝死(SCD)等事件在基因型阳性患者中并未更高(13%对9%)(p = 0.25)。54%的基因型阳性SQTS患者表现为SQTS 1型,其次是SQTS 2型(21%)和SQTS 3型(10%)。
基因型阳性患者发生恶性心律失常事件的长期风险并不更高。然而,基因型阳性患者更常出现心房颤动,且以女性为主。此外,随访期间的其他事件如晕厥、心房扑动和心悸等也没有显著更高(9%对0%;p = 0.079)。